Acknowledgments
The opinion expressed in this review is my own, and cannot be considered to reflect that of the agency.
Funding and conflict of interest
No sources of funding were used to assist in the preparation of this book review. Peter Mol has no conflicts of interest that are directly relevant to the content of this book review.
Author information
Authors and Affiliations
Corresponding author
Additional information
Peter Mol is also an employee of the Dutch Medicines Evaluation Board.
Rights and permissions
About this article
Cite this article
Mol, P. Therapeutic Risk Management of Medicines. Drug Saf 37, 1067–1068 (2014). https://doi.org/10.1007/s40264-014-0233-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40264-014-0233-0